{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:31Z","timestamp":1787756011296,"version":"build-2784847793"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The main components of gastroesophageal reflux disease (GERD) management include a combination of medications and lifestyle modifications; Nevertheless, based on the severity of symptoms and their response to medications, other treatments could be considered. Baclofen has been demonstrated in studies to relieve GERD symptoms. The current study aimed to precisely address the effects of baclofen on the treatment of GERD and its characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was carried out in Pubmed\/Medline, Cochrane CENTRAL, Scopus, Google Scholar, Web of Science, and <jats:ext-link>clinicaltrials.gov<\/jats:ext-link> up to December 10, 2021. The search terms included baclofen, GABA agonists, GERD, and reflux.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We selected 26 papers that matched the inclusion criteria after examining 727 records. Studies were classified into four categories based on the study population and reported outcomes: (1) adults, (2) children, (3) patients with gastroesophageal reflux-induced chronic cough, (4) hiatal hernia patients. The results revealed that baclofen can significantly improve reflux symptoms and pH-monitoring and manometry findings to different degrees in all four mentioned categories; although its effect on pH-monitoring parameters seems less significant than the other parameters. Mild neurological and mental status deterioration were the most reported side effects. However, side effects occurred in a portion of less than 5% of short-term users and nearly 20% of long-term users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In PPI-resistant patients, a trial of adding baclofen to the PPI may be helpful. Baclofen therapies may be more beneficial for symptomatic GERD patients who also report concurrent conditions including alcohol use disorder, non-acid reflux, or obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.997440","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T05:05:19Z","timestamp":1676610319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Baclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials"],"prefix":"10.3389","volume":"10","author":[{"given":"Erfan","family":"Arabpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Khoshdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Akhgarzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadamin","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Tabatabaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsa","family":"Alijanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdehagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.","volume":"101","author":"Vakil","year":"2006","journal-title":"Am Coll Gastroenterol."},{"key":"B2","first-page":"1","article-title":"Management of gastroesophageal reflux disease in pediatric patients: a literature review.","volume":"6","author":"Esposito","year":"2015","journal-title":"Pediatric Health Med Ther."},{"key":"B3","doi-asserted-by":"crossref","first-page":"e1684","DOI":"10.1542\/peds.2013-0421","article-title":"Gastroesophageal reflux: management guidance for the pediatrician.","volume":"131","author":"Lightdale","year":"2013","journal-title":"Pediatrics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S2468-1253(20)30007-8","article-title":"The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global burden of disease study 2017.","volume":"5","author":"Kamangar","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease.","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2017.07.049","article-title":"Management of gastroesophageal reflux disease.","volume":"154","author":"Gyawali","year":"2018","journal-title":"Gastroenterology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/TCRM.S296680","article-title":"Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review.","volume":"17","author":"Zhang","year":"2021","journal-title":"Ther Clin Risk Manag."},{"key":"B8","first-page":"515","article-title":"Physiology and pathogenesis of gastroesophageal reflux disease.","volume":"95","author":"Mikami","year":"2015","journal-title":"Surg Clin."},{"key":"B9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2017.09.047","article-title":"Pathophysiology of gastroesophageal reflux disease.","volume":"154","author":"Tack","year":"2018","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"20503121211022197","DOI":"10.1177\/20503121211022197","article-title":"Baclofen therapeutics, toxicity, and withdrawal: a narrative review.","volume":"9","author":"Romito","year":"2021","journal-title":"SAGE Open Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/gut.50.1.19","article-title":"Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.","volume":"50","author":"Zhang","year":"2002","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"307805","DOI":"10.1155\/2014\/307805","article-title":"The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials.","volume":"2014","author":"Li","year":"2014","journal-title":"Gastroenterol Res Pract."},{"key":"B13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med."},{"key":"B14","year":"2021","journal-title":"Study quality assessment tools."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/ajg.2009.247","article-title":"Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy.","volume":"104","author":"Beaumont","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gut.52.4.464","article-title":"Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.","volume":"52","author":"Ciccaglione","year":"2003","journal-title":"Gut."},{"key":"B17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"A pharmacological option for the treatment of GERD in infants effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial.","volume":"71","author":"Dibner","year":"2006","journal-title":"Rev Gastroenterol M\u00e9x."},{"key":"B18","first-page":"1221","article-title":"Effect of a combination of omeprazole plus sustained release baclofen versus omeprazole alone on symptoms of patients with gastroesophageal reflux disease (GERD).","volume":"13","author":"Abbasinazari","year":"2014","journal-title":"Iran J Pharm Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000221146","article-title":"High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease -A prospective pH-metry\/impedance-controlled study.","volume":"80","author":"Bajbouj","year":"2009","journal-title":"Digestion."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/gut.52.10.1397","article-title":"Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.","volume":"52","author":"Koek","year":"2003","journal-title":"Gut."},{"key":"B21","first-page":"11287","article-title":"The efficacy of baclofen to treat gastroesophageal reflux disease in children aged 6 months to 12 years: a clinical trial study.","volume":"8","author":"Sobhani Shahmirzadi","year":"2020","journal-title":"Int J Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3978\/j.issn.2072-1439.2016.01.50","article-title":"A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough.","volume":"8","author":"Xu","year":"2016","journal-title":"J Thorac Dis."},{"key":"B23","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.3748\/wjg.v19.i27.4386","article-title":"Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.","volume":"19","author":"Xu","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00005176-200403000-00017","article-title":"Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease.","volume":"38","author":"Kawai","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1365-2036.2012.05068.x","article-title":"Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux\u2013a randomised prospective study.","volume":"35","author":"Cossentino","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/ajg.2011.121","article-title":"Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.","volume":"106","author":"Vakil","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/apt.12956","article-title":"Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study.","volume":"40","author":"Curcic","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"B29","first-page":"15","article-title":"The effect of baclofen on treatment of infancy gastro-esophageal reflux disorder.","volume":"18","author":"Khodadad","year":"2008","journal-title":"Iran J Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2982.2012.01900.x","article-title":"The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial.","volume":"24","author":"Orr","year":"2012","journal-title":"Neurogastroenterol Motil."},{"key":"B31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1046\/j.1365-2036.2002.01250.x","article-title":"Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease.","volume":"16","author":"Cange","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1365-2982.2008.01115.x","article-title":"Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.","volume":"20","author":"Grossi","year":"2008","journal-title":"Neurogastroenterol Motil."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/dote.12443","article-title":"Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.","volume":"29","author":"Scarpellini","year":"2016","journal-title":"Dis Esophagus."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2002.01325.x","article-title":"The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.","volume":"16","author":"van Herwaarden","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"B35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial.","volume":"149","author":"Omari","year":"2006","journal-title":"J Pediatr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/WNR.0000000000001155","article-title":"Molecular mechanisms of the antispasticity effects of baclofen on spinal ventral horn neurons.","volume":"30","author":"Abe","year":"2019","journal-title":"Neuroreport."},{"key":"B37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1345\/aph.1C465","article-title":"Baclofen treatment for chronic posttraumatic stress disorder.","volume":"37","author":"Drake","year":"2003","journal-title":"Ann Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41424-018-0010-y","article-title":"Baclofen and gastroesophageal reflux disease: seeing the forest through the trees.","volume":"9","author":"Clarke","year":"2018","journal-title":"Clin Transl Gastroenterol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/8755122515586835","article-title":"The role of baclofen in the treatment of gastroesophageal reflux disease.","volume":"31","author":"Warren","year":"2015","journal-title":"J Pharm Technol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2340\/16501977-2211","article-title":"Efficacy and safety of oral baclofen in the management of spasticity: a rationale for intrathecal baclofen.","volume":"49","author":"Ertzgaard","year":"2017","journal-title":"J Rehabil Med."},{"key":"B41","author":"Ghanavatian","year":"2021","journal-title":"Baclofen."},{"key":"B42","doi-asserted-by":"publisher","first-page":"106439","DOI":"10.1016\/j.rmed.2021.106439","article-title":"Pressure and length of the lower esophageal sphincter as predictive indicators of therapeutic efficacy of baclofen for refractory gastroesophageal reflux-induced chronic cough.","volume":"183","author":"Zhu","year":"2021","journal-title":"Respir Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13302","DOI":"10.1111\/nmo.13302","article-title":"Cardiovascular safety of prokinetic agents: a focus on drug-induced arrhythmias.","volume":"30","author":"Giudicessi","year":"2018","journal-title":"Neurogastroenterol Motil."},{"key":"B44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/BF01536799","article-title":"Comparison of effects of upright versus supine body position and liquid versus solid bolus on esophageal pressures in normal humans.","volume":"35","author":"Sears","year":"1990","journal-title":"Dig Dis Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"765061","DOI":"10.3389\/fmed.2021.765061","article-title":"Refractory gastroesophageal reflux disease: a management update.","volume":"8","author":"Rettura","year":"2021","journal-title":"Front Med."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized trial of medical versus surgical treatment for refractory heartburn.","volume":"381","author":"Spechler","year":"2019","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/alcalc\/agy063","article-title":"Alcohol consumption and the risk of gastroesophageal reflux disease: a systematic review and meta-analysis.","volume":"54","author":"Pan","year":"2019","journal-title":"Alcohol Alcohol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fpsyt.2018.00708","article-title":"The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective.","volume":"9","author":"De Beaurepaire","year":"2019","journal-title":"Front Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ajg.2017.441","article-title":"A randomized double-blind, placebo-controlled, cross-over study using baclofen in the treatment of rumination syndrome.","volume":"113","author":"Pauwels","year":"2018","journal-title":"Am Coll Gastroenterol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11894-020-00780-4","article-title":"Non-acid reflux: when it matters and approach to management.","volume":"22","author":"Zikos","year":"2020","journal-title":"Curr Gastroenterol Rep."},{"key":"B51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2169\/internalmedicine.49.3918","article-title":"Positive effect of baclofen on body weight reduction in obese subjects: a pilot study.","volume":"49","author":"Arima","year":"2010","journal-title":"Intern Med."},{"key":"B53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease.","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/ajg.2009.718","article-title":"Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.","volume":"105","author":"Gerson","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/MPG.0b013e3182a2747b","article-title":"Baclofen for the treatment of pediatric GERD.","volume":"57","author":"Vadlamudi","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-9974-8-8","article-title":"Successful resolution of refractory chronic cough induced by gastroesophageal reflux with treatment of baclofen.","volume":"8","author":"Xu","year":"2012","journal-title":"Cough."},{"key":"B57","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1365-2036.2009.04107.x","article-title":"The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.","volume":"30","author":"Beaumont","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"key":"B58","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1365-2036.2010.04283.x","article-title":"Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects.","volume":"31","author":"Boeckxstaens","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0016-5085(00)70408-2","article-title":"Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects.","volume":"118","author":"Lidums","year":"2000","journal-title":"Gastroenterology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cgh.2011.10.042","article-title":"Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching.","volume":"10","author":"Blondeau","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/JCP.0000000000000332","article-title":"Treatment of binge eating disorder with high-dose baclofen: a case series.","volume":"35","author":"De Beaurepaire","year":"2015","journal-title":"J Clin Psychopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/apt.15169","article-title":"Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.","volume":"49","author":"Dong","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21037\/atm.2019.09.162","article-title":"Reflux characteristics in patients with gastroesophageal reflux-related chronic cough complicated by laryngopharyngeal reflux.","volume":"7","author":"Yu","year":"2019","journal-title":"Ann Transl Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2982.2010.01537.x","article-title":"Treatment of gastro-esophageal reflux disease: the new kids to block: VIEWPOINT.","volume":"22","author":"Blondeau","year":"2010","journal-title":"Neurogastroenterol Motil."},{"key":"B65","first-page":"A3668","article-title":"Association of esophageal dysfunction with therapeutic efficacy of baclofen in patients with refractory gastroesophageal reflux-induced chronic cough.","volume":"50","author":"Xu","year":"2017","journal-title":"Eur Respir Soc."},{"key":"B66","first-page":"725","article-title":"Efficacy of baclofen combined with esomeprazole and mosapride on refractory gastroesophageal reflux disease.","volume":"19","author":"Wu","year":"2014","journal-title":"Chin J Gastroenterol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S963","DOI":"10.1111\/jgh.14404","article-title":"Tu1600-gaba-B agonist baclofen inhibits acid-induced excitation of secondary peristalsis but not heartburn sensation.","volume":"154","author":"Chen","year":"2018","journal-title":"Gastroenterology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.997440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T05:05:34Z","timestamp":1676610334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.997440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":67,"alternative-id":["10.3389\/fmed.2023.997440"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.997440","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"article-number":"997440"}}